Combination of KRASG12C(ON) and SHP2 inhibitors overcomes adaptive resistance and enhances anti-tumour immunity. (October 2022) - Anastasiou, P.; Boumelha, J.; Mugarza, E.; Rana, S.; Moore, C.; Molina Arcas, M.; Downward, J.